Incyclix Bio LLC
Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients.
Company Location
600 Park Offices Drive, Suite 355
Research Triangle Park
NC
27709
Phone
County
Region
Company Details
Company type
Year founded
2020
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
INX-315, a potent and selective CDK2 inhibitor nearing clinical stage